Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00177398 · ClinicalTrials.gov registry record · Phase 4
Effect of Glargine Insulin on Glucose Control in Hospitalized Patients Who Receive Tube Feedings
A Phase 4 study, sponsored by University of Pittsburgh.
- Completed
- Registry status
- Phase 4
- Development phase
- 50
- Enrollment target
NCT00177398 is a Phase 4 study that has completed, run by University of Pittsburgh. The registered enrollment target is 50 participants.
The verdict
NCT00177398, a Phase 4 study, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 50 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if the early initiation of a long acting insulin (i.e. glargine) with supplemental doses of short acting regular (SSR) insulin in hospitalized patients with diabetes who are fed using tube feedings reduces the frequency of high and low blood sugar levels when compared to use of SSR insulin alone.
Interventions
- DRUG Glargine insulin vs regular insulin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2005-02 |
| Est. Completion | 2006-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00177398
The ClinicalTrials.gov registry entry for NCT00177398 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Glargine insulin vs regular insulin is the first listed.
NCT00177398 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00177398 about?
NCT00177398 is a clinical study titled "Effect of Glargine Insulin on Glucose Control in Hospitalized Patients Who Receive Tube Feedings". The purpose of this study is to determine if the early initiation of a long acting insulin (i.e. glargine) with supplemental doses of short acting regular (SSR) insulin in hospitalized patients with diabetes who are fed using tube feedings reduces the frequency of high and low blood sugar levels whe...
What is the current status of trial NCT00177398?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 50 participants. The study started on 2005-02. Estimated completion is 2006-08.
What interventions are being tested in trial NCT00177398?
The interventions under investigation include: Glargine insulin vs regular insulin (DRUG).
Who is sponsoring clinical trial NCT00177398?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.